Setting Alert and Action Limits in the Presence of Significant Amount of Censoring in Data

References

1. 1.↵
   FDA Guidance for industry. Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice, (2004); http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070342.pdf. Accessed 25 March 2016.
2. 2.↵
   EU Guidelines to Good Manufacturing Practice Medicinal Products for Human and Veterinary Use—Annex 1 Manufacture of Sterile Medicinal Products (corrected version, 2008; http://ec.europa.eu/health/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf. Accessed 25 March 2016.
3. 3.↵
   USP<1116> Microbiological Control and Monitoring of Aseptic Processing Environments, 2013. http://www.ccv.com.ve/SalasLimpias/USP_1116_USP_36_NF31S1.pdf. Accessed 25 March 2016.
4. 4.↵
   1. Sutton S.

   The environmental monitoring program in a GMP environment. Journal of GXP Compliance 2010, 14 (3), 22–30.

   OpenUrl
5. 5.↵
   1. Wheeler D.

   Advanced Topics in Statistical Process Control: The Power of Shewhart's Charts, 2nd ed.; SPC Press: Knoxville, TN, 2004.
6. 6.↵
   1. Yang H.,
   2. Zhao W.,
   3. O'Day T.,
   4. Fleming W.

   Environmental monitoring: setting alert and action limits based on a zero-inflated model. PDA J. Pharm. Sci. Technol. 2013, 67 (1), 2–8.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Tobin J.

   Estimation of Relationships for Limited Dependent Variables. Econometrica 1958, 26 (1), 24–36.

   OpenUrlCrossRefWeb of Science
8. 8.↵
   1. Davidian M.,
   2. Giltinan D. M.

   Nonlinear Models for Repeated Measurement Data; Chapman & Hall: New York, 1995.
9. 9.↵
   1. Bates D. M.,
   2. DebRoy S.

   Linear Mixed Models and Penalized Least Squares. Journal of Multivariate Analysis 2004, 91 (1), 1–17.

   OpenUrlCrossRefWeb of Science
10. 10.↵
    1. Gelman A.,
    2. Carlin J.,
    3. Stern H.,
    4. Rubin D.

    Bayesian Data Analysis, 2nd ed.; Chapman & Hall: New York, 2004.
11. 11.↵
    1. Harville D. A.

    Bayesian Inference for Variance Components Using Only Error Contrasts. Biometrika 1974, 61 (2), 383–385.

    OpenUrlCrossRefWeb of Science
12. 12.↵
    1. Liao C. T.,
    2. Lin T. Y.,
    3. Iyer H. K.

    One- and Two-Sided Tolerance Intervals for General Balanced Mixed Models and Unbalanced One-Way Random Models. Technometrics 2005, 47 (3), 323–335.

    OpenUrlCrossRefWeb of Science
13. 13.↵
    1. Efron B.,
    2. Tibshirani R. J.

    An Introduction to the Bootstrap; Chapman & Hall: New York, 1993.
14. 14.↵
    1. Casella G.,
    2. Berger R. L.

    Chapter 10, Decision Theory. Statistical Inference; Duxbury Press: Belmont, CA, 2002.
15. 15.↵
    1. Lunn D.,
    2. Spiegelhalter D.,
    3. Thomas A.,
    4. Best N.

    The BUGS Project: Evolution, Critique and Future Directions. Statistics in Medicine 2009, 28 (25), 3049–3067.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Plummer M.

    JAGS: A Program for Analysis of Bayesian Graphical Models Using Gibbs Sampling. In Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003), Vienna, Austria, March 20–22, 2003; ISSN 1609–395X.
17. 17.↵
    Stan Development Team, (2016). Stan Modeling Language Users Guide and Reference Manual, Version 2.9.0. http://mc-stan.org
18. 18.↵
    SAS Institute Inc. SAS/STAT^® 9.2 User's Guide, 2nd ed.; SAS Institute, Inc.: Cary, NC, 2009.
19. 19.↵
    1. Royston J. P.

    Approximating the Shapiro-Wilk W-Test for Non-Normality. Statistics and Computing 1992, 2 (3), 117–119.

    OpenUrl
20. 20.↵
    1. Royston P. A.

    Toolkit for Testing for Non-Normality in Complete and Censored Samples. The Statistician 1993, 42 (1), 37–43.

    OpenUrl